Search

Dennis Michael White

Examiner (ID: 16861, Phone: (571)270-3747 , Office: P/1798 )

Most Active Art Unit
1798
Art Unit(s)
1798, 1772, 1797, 1758
Total Applications
1072
Issued Applications
664
Pending Applications
68
Abandoned Applications
364

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 8257652 [patent_doc_number] => 08207132 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-06-26 [patent_title] => 'Recombinant vaccines against caligid copepods (sea lice) and antigen sequences thereof' [patent_app_type] => utility [patent_app_number] => 11/572719 [patent_app_country] => US [patent_app_date] => 2005-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 5736 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11572719 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/572719
Recombinant vaccines against caligid copepods (sea lice) and antigen sequences thereof Jul 27, 2005 Issued
Array ( [id] => 5769160 [patent_doc_number] => 20060019921 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-26 [patent_title] => 'Nucleic acid adjuvants' [patent_app_type] => utility [patent_app_number] => 11/179798 [patent_app_country] => US [patent_app_date] => 2005-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 28773 [patent_no_of_claims] => 62 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0019/20060019921.pdf [firstpage_image] =>[orig_patent_app_number] => 11179798 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/179798
Nucleic acid adjuvants Jul 12, 2005 Abandoned
Array ( [id] => 4651530 [patent_doc_number] => 20080038786 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-02-14 [patent_title] => 'Method of Producing Substance' [patent_app_type] => utility [patent_app_number] => 11/630396 [patent_app_country] => US [patent_app_date] => 2005-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6400 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0038/20080038786.pdf [firstpage_image] =>[orig_patent_app_number] => 11630396 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/630396
Process for producing L-glutamine using Escherichia coli with deficient glnB and glnE function Jun 23, 2005 Issued
Array ( [id] => 4853125 [patent_doc_number] => 20080318868 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-25 [patent_title] => 'Use of Mycobacterial Mannosylated Lipoglycans Peptide Mimotopes For Treating Inflammation' [patent_app_type] => utility [patent_app_number] => 11/630115 [patent_app_country] => US [patent_app_date] => 2005-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 14257 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0318/20080318868.pdf [firstpage_image] =>[orig_patent_app_number] => 11630115 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/630115
Use of mycobacterial mannosylated lipoglycans peptide mimotopes for treating inflammation Jun 22, 2005 Issued
Array ( [id] => 5397349 [patent_doc_number] => 20090317412 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-24 [patent_title] => 'Induction of an immune response against streptococcus pneumoniae polyaccharides' [patent_app_type] => utility [patent_app_number] => 11/628265 [patent_app_country] => US [patent_app_date] => 2005-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15214 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0317/20090317412.pdf [firstpage_image] =>[orig_patent_app_number] => 11628265 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/628265
Induction of an immune response against streptococcus pneumoniae polyaccharides Jun 2, 2005 Abandoned
Array ( [id] => 7046131 [patent_doc_number] => 20050250726 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-10 [patent_title] => 'Immunostimulatory nucleic acid for treatment of non-allergic inflammatory diseases' [patent_app_type] => utility [patent_app_number] => 11/127654 [patent_app_country] => US [patent_app_date] => 2005-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 28015 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0250/20050250726.pdf [firstpage_image] =>[orig_patent_app_number] => 11127654 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/127654
Immunostimulatory nucleic acid for treatment of non-allergic inflammatory diseases May 11, 2005 Abandoned
Array ( [id] => 7068997 [patent_doc_number] => 20050244380 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-03 [patent_title] => 'Immunomodulatory oligonucleotides' [patent_app_type] => utility [patent_app_number] => 11/128127 [patent_app_country] => US [patent_app_date] => 2005-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11217 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0244/20050244380.pdf [firstpage_image] =>[orig_patent_app_number] => 11128127 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/128127
Immunomodulatory oligonucleotides May 10, 2005 Abandoned
Array ( [id] => 7068997 [patent_doc_number] => 20050244380 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-03 [patent_title] => 'Immunomodulatory oligonucleotides' [patent_app_type] => utility [patent_app_number] => 11/128127 [patent_app_country] => US [patent_app_date] => 2005-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11217 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0244/20050244380.pdf [firstpage_image] =>[orig_patent_app_number] => 11128127 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/128127
Immunomodulatory oligonucleotides May 10, 2005 Abandoned
Array ( [id] => 6944359 [patent_doc_number] => 20050196408 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-08 [patent_title] => 'Method of administering FimH protein as a vaccine for urinary tract infections' [patent_app_type] => utility [patent_app_number] => 11/110609 [patent_app_country] => US [patent_app_date] => 2005-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 24133 [patent_no_of_claims] => 209 [patent_no_of_ind_claims] => 208 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0196/20050196408.pdf [firstpage_image] =>[orig_patent_app_number] => 11110609 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/110609
Method of administering FimH protein as a vaccine for urinary tract infections Apr 18, 2005 Abandoned
Array ( [id] => 7220247 [patent_doc_number] => 20050260692 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-24 [patent_title] => 'Positive selection in the immuno-dominant surface antigen 1 (SAG1) of sarcocystis neurona, agent of EPM: potential as a diagnostic reagent and as a component of a sub-unit vaccine' [patent_app_type] => utility [patent_app_number] => 11/105236 [patent_app_country] => US [patent_app_date] => 2005-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 16982 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0260/20050260692.pdf [firstpage_image] =>[orig_patent_app_number] => 11105236 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/105236
Positive selection in the immuno-dominant surface antigen 1 (SAG1) of sarcocystis neurona, agent of EPM: potential as a diagnostic reagent and as a component of a sub-unit vaccine Apr 12, 2005 Abandoned
Array ( [id] => 5585012 [patent_doc_number] => 20090104214 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-23 [patent_title] => 'Synthetic peptides containing the motif \"YWWLXP\" as anthrax toxin antidotes' [patent_app_type] => utility [patent_app_number] => 11/547092 [patent_app_country] => US [patent_app_date] => 2005-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 6336 [patent_no_of_claims] => 61 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0104/20090104214.pdf [firstpage_image] =>[orig_patent_app_number] => 11547092 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/547092
Synthetic peptides containing the motif "YWWLXP" as anthrax toxin antidotes Mar 24, 2005 Abandoned
Array ( [id] => 5336802 [patent_doc_number] => 20090053266 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-26 [patent_title] => 'Apicomplex vaccine strains of a family of sarcocystidae' [patent_app_type] => utility [patent_app_number] => 10/585721 [patent_app_country] => US [patent_app_date] => 2005-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 8622 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20090053266.pdf [firstpage_image] =>[orig_patent_app_number] => 10585721 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/585721
Apicomplex vaccine strains of a family of Sarcocystidae Jan 12, 2005 Issued
Array ( [id] => 4921529 [patent_doc_number] => 20080069844 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-03-20 [patent_title] => 'Mucosal Vaccine Adjuvants Containing Bacterial Flagellins as an Active Component' [patent_app_type] => utility [patent_app_number] => 10/585880 [patent_app_country] => US [patent_app_date] => 2005-01-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 4966 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0069/20080069844.pdf [firstpage_image] =>[orig_patent_app_number] => 10585880 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/585880
Mucosal vaccine adjuvants containing bacterial flagellins as an active component Jan 11, 2005 Issued
Array ( [id] => 5799375 [patent_doc_number] => 20060034871 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-16 [patent_title] => 'Immunogenic compositions for Chlamydia trachomatis' [patent_app_type] => utility [patent_app_number] => 11/018868 [patent_app_country] => US [patent_app_date] => 2004-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 48227 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0034/20060034871.pdf [firstpage_image] =>[orig_patent_app_number] => 11018868 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/018868
Immunogenic compositions for Chlamydia trachomatis Dec 21, 2004 Pending
Array ( [id] => 7199851 [patent_doc_number] => 20050164931 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-28 [patent_title] => 'Protein ACA1 of antrodia camphorata' [patent_app_type] => utility [patent_app_number] => 11/015078 [patent_app_country] => US [patent_app_date] => 2004-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 7255 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0164/20050164931.pdf [firstpage_image] =>[orig_patent_app_number] => 11015078 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/015078
Protein ACA1 of Antrodia camphorata Dec 17, 2004 Issued
Array ( [id] => 4989309 [patent_doc_number] => 20070155650 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-07-05 [patent_title] => 'Use of cathepsin z inhibitors for the treatment of rhuematoid arthritis and other autoimmune diseases' [patent_app_type] => utility [patent_app_number] => 10/596815 [patent_app_country] => US [patent_app_date] => 2004-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 3410 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0155/20070155650.pdf [firstpage_image] =>[orig_patent_app_number] => 10596815 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/596815
Use of cathepsin z inhibitors for the treatment of rhuematoid arthritis and other autoimmune diseases Dec 13, 2004 Abandoned
Array ( [id] => 5842214 [patent_doc_number] => 20060121031 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-08 [patent_title] => 'Relay vaccine' [patent_app_type] => utility [patent_app_number] => 11/004961 [patent_app_country] => US [patent_app_date] => 2004-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 11126 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0121/20060121031.pdf [firstpage_image] =>[orig_patent_app_number] => 11004961 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/004961
Relay vaccine Dec 6, 2004 Abandoned
Array ( [id] => 4976769 [patent_doc_number] => 20070218000 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-09-20 [patent_title] => 'Protein Nmb1125 and Use Thereof in Pharmaceutical Formulations' [patent_app_type] => utility [patent_app_number] => 10/580508 [patent_app_country] => US [patent_app_date] => 2004-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 6857 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0218/20070218000.pdf [firstpage_image] =>[orig_patent_app_number] => 10580508 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/580508
Protein NMB1125 and use thereof in pharmaceutical formulations Dec 1, 2004 Issued
Array ( [id] => 6957951 [patent_doc_number] => 20050214321 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-29 [patent_title] => 'Recombinant icosahedral virus like particle production in pseudomonads' [patent_app_type] => utility [patent_app_number] => 11/001626 [patent_app_country] => US [patent_app_date] => 2004-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 28588 [patent_no_of_claims] => 85 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0214/20050214321.pdf [firstpage_image] =>[orig_patent_app_number] => 11001626 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/001626
Recombinant icosahedral virus like particle production in pseudomonads Nov 30, 2004 Abandoned
Array ( [id] => 6951843 [patent_doc_number] => 20050226937 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-13 [patent_title] => 'Use of hyaluronic acid polymers for mucosal delivery of vaccine and adjuvants' [patent_app_type] => utility [patent_app_number] => 11/001563 [patent_app_country] => US [patent_app_date] => 2004-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 10080 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0226/20050226937.pdf [firstpage_image] =>[orig_patent_app_number] => 11001563 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/001563
Use of hyaluronic acid polymers for mucosal delivery of vaccine and adjuvants Nov 29, 2004 Abandoned
Menu